Efficacy and safety of Idecabtagene Vicleucel (ide-cel, bb2121) in elderly patients (Pts) with relapsed and refractory multiple myeloma (RRMM): KarMMa subgroup analysisH. Einsele,J. Berdeja,N. S. Raje,D. S. Siegel,Y. Lin,L. D. Anderson,P. Rodriguez-Otero,S. Manier,M. Cavo,A. Truppel-Hartmann,E. Rowe, J. Sanford,J. Wang,T. B. Campbell,S. JagannathBLOOD(2021)引用 18|浏览22暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要